These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20643110)

  • 1. The protein Nod2: an innate receptor more complex than previously assumed.
    Lecat A; Piette J; Legrand-Poels S
    Biochem Pharmacol; 2010 Dec; 80(12):2021-31. PubMed ID: 20643110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards an understanding of the role of NOD2/CARD15 in the pathogenesis of Crohn's disease.
    Philpott DJ; Viala J
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):555-68. PubMed ID: 15157827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immune sensing of microbes by Nod proteins.
    Kufer TA; Banks DJ; Philpott DJ
    Ann N Y Acad Sci; 2006 Aug; 1072():19-27. PubMed ID: 17057187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
    Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
    Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.
    Maeda S; Hsu LC; Liu H; Bankston LA; Iimura M; Kagnoff MF; Eckmann L; Karin M
    Science; 2005 Feb; 307(5710):734-8. PubMed ID: 15692052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
    Peyrin-Biroulet L; Chamaillard M
    J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide expression profiling identifies an impairment of negative feedback signals in the Crohn's disease-associated NOD2 variant L1007fsinsC.
    Billmann-Born S; Till A; Arlt A; Lipinski S; Sina C; Latiano A; Annese V; Häsler R; Kerick M; Manke T; Seegert D; Hanidu A; Schäfer H; van Heel D; Li J; Schreiber S; Rosenstiel P
    J Immunol; 2011 Apr; 186(7):4027-38. PubMed ID: 21335489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired innate immunity in Crohn's disease.
    Comalada M; Peppelenbosch MP
    Trends Mol Med; 2006 Sep; 12(9):397-9. PubMed ID: 16890491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.
    Damgaard RB; Gyrd-Hansen M
    Discov Med; 2011 Mar; 11(58):221-31. PubMed ID: 21447281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
    Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
    Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial invasion: linking autophagy and innate immunity.
    Galluzzi L; Kepp O; Zitvogel L; Kroemer G
    Curr Biol; 2010 Feb; 20(3):R106-8. PubMed ID: 20144769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-based reporter assay to analyze activation of Nod1 and Nod2.
    Zurek B; Bielig H; Kufer TA
    Methods Mol Biol; 2011; 748():107-19. PubMed ID: 21701969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOD2-associated diseases: Bridging innate immunity and autoinflammation.
    Borzutzky A; Fried A; Chou J; Bonilla FA; Kim S; Dedeoglu F
    Clin Immunol; 2010 Mar; 134(3):251-61. PubMed ID: 19467619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton.
    Legrand-Poels S; Kustermans G; Bex F; Kremmer E; Kufer TA; Piette J
    J Cell Sci; 2007 Apr; 120(Pt 7):1299-310. PubMed ID: 17356065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens.
    Hsu YM; Zhang Y; You Y; Wang D; Li H; Duramad O; Qin XF; Dong C; Lin X
    Nat Immunol; 2007 Feb; 8(2):198-205. PubMed ID: 17187069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.